Previous Page  9 / 13 Next Page
Information
Show Menu
Previous Page 9 / 13 Next Page
Page Background

35

Find More Information @

https://obesity.conferenceseries.com

March 2019 Conference Series LLC Ltd

conferenceseries LLC Ltd

19

th

International Conference on

Obesity, Healthcare - Nutrition & Fitness

March 18 - 19, 2019 | New York, USA

GC-MS and molecular

docking studies for

identification of anti-

diabetic compounds

in methanolic extract

of

hunteria umbellata

seeds

Olusola Abiola Ladokun

Lead City University, Nigeria

T

he purpose of this

study was to investigate

the diabetic effect of

phytocompounds synthesized

from

Hunteria umbellata

using

GC-MS analysis and molecular

docking studies. Peroxisome

proliferator-activated receptor

gamma (PPAR-γ) agonists are

beneficial in the treatment of

diabetes by stimulating insulin

sensitivity and antagonizing

hepatic gluconeogenesis. The

aim of the present study was

to investigate PPAR-γ agonist

property of phytocompounds

from

Hunteria umbellata

using in-silico approach.

Molecular docking of

Hunteria

umbellata

on human PPAR-γ

protein was determined by

Auto/Vina in Pymol 4.2 and

compared with Gilbenclamide,

a known agonist of PPAR-γ.

Our present study reports

the phytochemical analysis of

the extracts of the seeds and

leaves of

Hunteria umbellata

.

21 compounds were revealed

through GC-MS analysis and

screened using Autodock/

Vina against PPAR-γ. Docking

studies recommended

that 2,2-Benzylidenebis

(3-methylbenzofuran) an

existing phytochemical

from the seed of

Hunteria

umbellata

had the highest

fitness score of-11.3 Kcal/mol

and hence could be a potent

antidiabetic drug.

Hunteria

umbellata

seed extract and its

compound 2,2-Benzylidenebis

(3-methylbenzofuran) have a

significant antidiabetic activity

against PPAR-γ. Molecular

binding interaction of an

in-silico data demonstrated

that 2,2-Benzylidenebis

(3-methylbenzofuran) has

more specificity towards

the PPAR-γ binding site and

could be a potent antidiabetic

compound.

Biography

Olusola Abiola Ladokun is

a Professor of Nutritional

Biochemistry in the

Department of Biochemistry,

Faculty of Sciences, Lead

City University, Ibadan. She

holds a PhD in Agricultural

Biochemistry and Nutrition

from the University of Ibadan,

Ibadan, Nigeria. She is the

current serving Dean of the

Faculty of Basic Medical and

Applied Sciences. She has to

her credit several articles in

both local and international

journals, chapters in books and

conference proceedings. Her

areas of research include but

not limited to Food Chemistry,

Ethnopharmacology, and

Functional Foods. She has

attended and presented papers

in conferences and workshops

in Nigeria and Internationally.

solaJP@gmail.com

SCIENTIFIC TRACKS

|

DAY 2

JOURNAL OF OBESITY &WEIGHT LOSS THERAPY 2019, VOLUME: 4 | DOI: 10.4172/2165-7904-C2-093